Log In
Print
BCIQ
Print
Print this Print this
 

epratuzumab (IMMU-103)

Also known as: formerly AMG 412, LymphoCide

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionHumanized mAb targeting CD22
Molecular Target CD22
Mechanism of ActionBinds CD22; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today